Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS3 | P17931 | 7/20 | 0.51 |
| ▸ | LGALS9 | O00182 | 4/20 | 0.51 |
| ▸ | LGALS1 | P09382 | 4/20 | 0.51 |
| ▸ | LGALS7; LGALS7B | P47929 | 3/20 | 0.51 |
| ▸ | LGALS4 | P56470 | 3/20 | 0.47 |
| ▸ | LGALS8 | O00214 | 6/20 | 0.46 |
| ▸ | MAOB | P27338 | 1/20 | 0.45 |
| ▸ | SELP | P16109 | 3/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.41 |
| ▸ | GBA1 | P04062 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8906431 | 1.00 | LGALS3 (0.51) | LGALS3LGALS9LGALS1LGALS7; LGALS7BLGALS4 | |
| SCHEMBL9702895 | 0.97 | LGALS3 (0.52) | LGALS3LGALS9LGALS1LGALS7; LGALS7BLGALS4 | |
| SCHEMBL9473032 | 0.92 | LGALS3 (0.46) | LGALS3LGALS9LGALS1LGALS7; LGALS7BLGALS4 | |
| SCHEMBL9473041 | 0.92 | LGALS3 (0.46) | LGALS3LGALS9LGALS1LGALS7; LGALS7BLGALS4 | |
| SCHEMBL8399805 | 0.86 | ANTXR2 (0.39) | LGALS3LGALS9LGALS1LGALS7; LGALS7BLGALS4 | |
| SCHEMBL8399808 | 0.86 | ANTXR2 (0.39) | LGALS3LGALS9LGALS1LGALS7; LGALS7BLGALS4 | |
| SCHEMBL6358847 | 0.82 | LGALS3 (0.57) | LGALS3LGALS9LGALS1LGALS7; LGALS7BLGALS4 | |
| SCHEMBL6358849 | 0.82 | LGALS3 (0.57) | LGALS3LGALS9LGALS1LGALS7; LGALS7BLGALS4 | |
| SCHEMBL7770718 | 0.81 | LGALS8 (0.50) | LGALS3LGALS8SELPGBA1MAPK1 | |
| SCHEMBL9798180 | 0.81 | LGALS8 (0.55) | LGALS3LGALS8SELP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5620902-A | BIOSYNTHESIS OF ANTIGENS; DIAGNOSIS, THERAPY | ALBERTA RESEARCH COUNCIL (CA) | 1997-04-15 | — | — | US | disclosed |
| US-5527901-A | TETRASACCHARIDES BONDING TO A LABEL, A CHROMATOGRAPIC SUPPORT OR PROTECTIVE GROUP FOR ISOLATING, PURIFYING ANTIBODIES | ALBERTA RESEARCH COUNCIL (CA) | 1996-06-18 | — | — | US | disclosed |
| US-5344870-A | Synthetic haptens, cancer treatment, stereospecific etherification of saccharides | ALBERTA RESEARCH COUNCIL (CA) | 1994-09-06 | — | — | US | disclosed |
| US-5296594-A | Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation | ALBERTA RESEARCH COUNCIL (CA) | 1994-03-22 | — | — | US | disclosed |
| EP-0560409-A2 | Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation | ALBERTA RESEARCH COUNCIL (CA) | 1993-09-15 | — | — | EP | disclosed |
| US-5079353-A | SIALIC ACID GLYCOSIDES, ANTIGENS, IMMUNOADSORBENTS, AND METHODS FOR THEIR PREPARATION | CHEMBIOMED, LTD. (CA) | 1992-01-07 | — | — | US | disclosed |
| EP-0319253-A2 | Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation | ALBERTA RESEARCH COUNCIL (CA) | 1989-06-07 | — | — | EP | disclosed |